Evaluation | Days after Enrolment | ||||
---|---|---|---|---|---|
 | 0 | 3–4 | 13–15 | 24–32 | 84–92 |
Notification to study center | X | Â | Â | Â | Â |
Entry criteria | X | Â | Â | Â | Â |
Written Informed Consent | X* | X* | Â | Â | Â |
Demography | X | Â | Â | Â | Â |
Clinical data | X | X | X | X | X |
(Serious) Adverse events | X | X | X | X | X |
Mortality | Â | X | X | X | X |
Blood culture | X | Â | Â | Â | Â |
Urine culture | X | Â | Â | X | Â |
Randomization and allocation to study treatment | Â | X | Â | Â | Â |
End of treatment assessment | Â | Â | X | Â | Â |
Contact – in person | X | X |  | X |  |
Contact – by phone |  |  | X |  | X |